ConductScience.org, home

Paper16636679

Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.

Sun C and 8 others. Oncogene, 2006. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival. Papers, record 16636679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16636679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.
PubMed
Journal
Oncogene
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2026-10-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun CC
2Shi YY
3Xu LLL L
4Nageswararao CC
5Davis LDL D
6Segawa TT
7Dobi AA
8McLeod DGD G
9Srivastava SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell DivisionMajor topic
Cell SurvivalMajor topic
Prostatic NeoplasmsMajor topic
Receptors, AndrogenMajor topic
Apoptosis
Cell Line, Tumor
Genes, p53
Genetic Vectors
Humans
Male
Transcriptional Activation

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112089231Molecular biology of the androgen receptor.J Clin Oncol2002https://conductscience.org/library/papers/12089231PubMed
27671222Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells.Cancer Res1995https://conductscience.org/library/papers/7671222PubMed
315540784Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells.J Urol2004https://conductscience.org/library/papers/15540784PubMed
49619361Update on the diagnosis and treatment of prostate cancer.Curr Opin Oncol1998https://conductscience.org/library/papers/9619361PubMed
57671257Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.Cancer Res1995https://conductscience.org/library/papers/7671257PubMed
611717329Androgen receptor signaling in androgen-refractory prostate cancer.J Natl Cancer Inst2001https://conductscience.org/library/papers/11717329PubMed
711156376HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.Cancer Res2000https://conductscience.org/library/papers/11156376PubMed
814702632Molecular determinants of resistance to antiandrogen therapy.Nat Med2004https://conductscience.org/library/papers/14702632PubMed
916007156Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.Oncogene2005https://conductscience.org/library/papers/16007156PubMed
1010618708mdm2: a bridge over the two tumour suppressors, p53 and Rb.Oncogene1999https://conductscience.org/library/papers/10618708PubMed
112260966A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.Biochem Biophys Res Commun1990https://conductscience.org/library/papers/2260966PubMed
129482916A simplified system for generating recombinant adenoviruses.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9482916PubMed
1315368466Epothilone induced cytotoxicity is dependent on p53 status in prostate cells.Prostate2004https://conductscience.org/library/papers/15368466PubMed
1411888926Functional analysis of 44 mutant androgen receptors from human prostate cancer.Cancer Res2002https://conductscience.org/library/papers/11888926PubMed
157502427Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.Urology1995https://conductscience.org/library/papers/7502427PubMed
1611900250The development of androgen-independent prostate cancer.Nat Rev Cancer2001https://conductscience.org/library/papers/11900250PubMed
1710200775Cancer statistics, 1999.CA Cancer J Clin1999https://conductscience.org/library/papers/10200775PubMed
1814518029Molecular characterization of human prostate carcinoma cell lines.Prostate2003https://conductscience.org/library/papers/14518029PubMed
199622059Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy.Cancer Res1998https://conductscience.org/library/papers/9622059PubMed
2015982869Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.J Steroid Biochem Mol Biol2005https://conductscience.org/library/papers/15982869PubMed

See all 35 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
42662529Asymmetric cross-reactivity of nuclear receptors reveals an evolutionary buffer between estrogen and androgen signaling.iScience2026https://conductscience.org/library/papers/42662529PubMed
40609538Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.Cell Rep Med2025https://conductscience.org/library/papers/40609538PubMed
40269952The role of androgens and global and tissue-specific androgen receptor expression on body composition, exercise adaptation, and performance.Biol Sex Differ2025https://conductscience.org/library/papers/40269952PubMed
38481034Discovery of Novel Anti-Resistance AR Antagonists Guided by Funnel Metadynamics Simulation.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38481034PubMed
37189723Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy.Biomedicines2023https://conductscience.org/library/papers/37189723PubMed
36672609Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition.Biomedicines2022https://conductscience.org/library/papers/36672609PubMed
36660947STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide.Mol Med Rep2023https://conductscience.org/library/papers/36660947PubMed
36639570Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance.Acta Pharmacol Sin2023https://conductscience.org/library/papers/36639570PubMed
36459502Yeast-based evolutionary modeling of androgen receptor mutations and natural selection.PLoS Genet2022https://conductscience.org/library/papers/36459502PubMed
36017332Simulating androgen receptor selection in designer yeast.Synth Syst Biotechnol2022https://conductscience.org/library/papers/36017332PubMed
35573198High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice.iScience2022https://conductscience.org/library/papers/35573198PubMed
35015785Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.PLoS One2022https://conductscience.org/library/papers/35015785PubMed
34193425In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer.Sci Adv2021https://conductscience.org/library/papers/34193425PubMed
31379747Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2.Front Endocrinol (Lausanne)2019https://conductscience.org/library/papers/31379747PubMed
30565014A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy.Horm Cancer2019https://conductscience.org/library/papers/30565014PubMed
30027434Androgenic modulation of AR-Vs.Endocrine2018https://conductscience.org/library/papers/30027434PubMed
28876465Procyanidin B2 3,3″-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK.Mol Carcinog2018https://conductscience.org/library/papers/28876465PubMed
28235766Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.Cancer Res2017https://conductscience.org/library/papers/28235766PubMed
27741508Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Oncotarget2017https://conductscience.org/library/papers/27741508PubMed
27302572Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.Int J Urol2016https://conductscience.org/library/papers/27302572PubMed

See all 44 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
RIEG26012PubTator's text mininghttps://conductscience.org/library/genes/6012NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16636679

GET https://conductscience.org/api/papers/v1/16636679/references?page=2